These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 8828460

  • 21. Structural features of thyroid hormone response elements that increase susceptibility to inhibition by an RTH mutant thyroid hormone receptor.
    Zavacki AM, Harney JW, Brent GA, Larsen PR.
    Endocrinology; 1996 Jul; 137(7):2833-41. PubMed ID: 8770904
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The function of retinoid X receptors on negative thyroid hormone response elements.
    Takeda T, Nagasawa T, Miyamoto T, Hashizume K, DeGroot LJ.
    Mol Cell Endocrinol; 1997 Apr 04; 128(1-2):85-96. PubMed ID: 9140079
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone.
    Sakurai A, Miyamoto T, Refetoff S, DeGroot LJ.
    Mol Endocrinol; 1990 Dec 04; 4(12):1988-94. PubMed ID: 2082193
    [Abstract] [Full Text] [Related]

  • 27. Retinoid X receptor-alpha and apolipoprotein AI regulatory protein 1 differentially modulate 3,5,3'-triiodothyronine-induced transcription.
    Rhee M, Ikeda M, Chin WW.
    Endocrinology; 1995 Jun 04; 136(6):2697-704. PubMed ID: 7750494
    [Abstract] [Full Text] [Related]

  • 28. Two thyroid hormone response elements are present in the promoter of human thyroid hormone receptor beta 1.
    Suzuki S, Miyamoto T, Opsahl A, Sakurai A, DeGroot LJ.
    Mol Endocrinol; 1994 Mar 04; 8(3):305-14. PubMed ID: 8015548
    [Abstract] [Full Text] [Related]

  • 29. A method for efficient production of recombinant thyroid hormone receptors reveals that receptor homodimer-DNA binding is enhanced by the coactivator TIF2.
    Diallo EM, Thompson DL, Koenig RJ.
    Protein Expr Purif; 2005 Apr 04; 40(2):292-8. PubMed ID: 15766871
    [Abstract] [Full Text] [Related]

  • 30. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
    Meier-Heusler SC, Zhu X, Juge-Aubry C, Pernin A, Burger AG, Cheng SY, Meier CA.
    Mol Cell Endocrinol; 1995 Jan 04; 107(1):55-66. PubMed ID: 7796935
    [Abstract] [Full Text] [Related]

  • 31. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity.
    Yagi H, Pohlenz J, Hayashi Y, Sakurai A, Refetoff S.
    J Clin Endocrinol Metab; 1997 May 04; 82(5):1608-14. PubMed ID: 9141558
    [Abstract] [Full Text] [Related]

  • 32. Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone.
    Meier CA, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ransom SC, Menke JB, Hao EH, Usala SJ, Bercu BB.
    Mol Endocrinol; 1992 Feb 04; 6(2):248-58. PubMed ID: 1569968
    [Abstract] [Full Text] [Related]

  • 33. Quantitative analysis of DNA binding affinity and dimerization properties of wild-type and mutant thyroid hormone receptor beta1.
    Takeda T, Nagasawa T, Miyamoto T, Minemura K, Hashizume K, Degroot LJ.
    Thyroid; 2000 Jan 04; 10(1):11-8. PubMed ID: 10691308
    [Abstract] [Full Text] [Related]

  • 34. Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone.
    Hayashi Y, Sunthornthepvarakul T, Refetoff S.
    J Clin Invest; 1994 Aug 04; 94(2):607-15. PubMed ID: 8040316
    [Abstract] [Full Text] [Related]

  • 35. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M, Tanen MR, Bagchi MK.
    Mol Endocrinol; 1997 Jun 04; 11(6):755-67. PubMed ID: 9171239
    [Abstract] [Full Text] [Related]

  • 36. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT.
    Matsushita A, Misawa H, Andoh S, Natsume H, Nishiyama K, Sasaki S, Nakamura H.
    J Endocrinol; 2000 Dec 04; 167(3):493-503. PubMed ID: 11115777
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations.
    Nagaya T, Eberhardt NL, Jameson JL.
    J Clin Endocrinol Metab; 1993 Oct 04; 77(4):982-90. PubMed ID: 8408475
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.